Researcher.Life Logo

FUTURE JOURNAL OF PHARMACEUTICAL SCIENCES : Impact Factor & More

eISSN: 2314-7253pISSN: 2314-7245
JournalOpen Access

Aims and Scope of FUTURE JOURNAL OF PHARMACEUTICAL SCIENCES

Future Journal of Pharmaceutical Sciences is issued under the auspices of Future University in Egypt. The Journal publishes communications, original research articles, review articles and case studies on all aspects of the pharmaceutical sciences and related clinical subjects that are of interest to all health professionals with strong emphasis on originality and scientific quality. Less

Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on FUTURE JOURNAL OF PHARMACEUTICAL SCIENCES

FUTURE JOURNAL OF PHARMACEUTICAL SCIENCES Journal Specifications

Overview
Publisher SPRINGER
Language English
Frequency Continuous publication
Publication Time23
Editorial Review ProcessDouble anonymous peer review
General Details
LanguageEnglish
Society/Institute/SponsorFuture University
FrequencyContinuous publication
Publication Start Year2015
Publisher URLVisit website
Website URLVisit website
Publication Details
Other chargesVisit website
PlagiarismVisit website
Publication Time 23
Editorial Review Detail
Editorial TeamVisit website
Review ProcessDouble anonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
License typeCC BY
OA statementVisit website
View less

Planning to publish in FUTURE JOURNAL OF PHARMACEUTICAL SCIENCES ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in FUTURE JOURNAL OF PHARMACEUTICAL SCIENCES

Enhanced antidiabetic efficacy and bioavailability of curcumin-loaded sporopollenin microcapsules in a type 2 diabetes rat model
  • 4 May 2026
  • Future Journal of Pharmaceutical Sciences
Antioxidant adjuvants as a strategy to combat multidrug-resistant gram-negative bacteria: mechanistic insights and translational perspectives
  • 16 Apr 2026
  • Future Journal of Pharmaceutical Sciences
Maintenance low-dose capecitabine versus observation in early-stage triple-negative breast cancer: a randomized controlled trial assessing safety with exploratory survival outcomes
  • 13 Apr 2026
  • Future Journal of Pharmaceutical Sciences
The double-edged sword of meat preservation: a review of nitrosamine genotoxicity, exposure in the egyptian market, and future alternatives
  • 13 Apr 2026
  • Future Journal of Pharmaceutical Sciences
Zinc and selenium in the management of subclinical hypothyroidism: mechanistic insights, clinical evidence, and translational perspectives
  • 13 Apr 2026
  • Future Journal of Pharmaceutical Sciences
Assessing the genetic contribution of certain GAS6/AXL variants to diabetic kidney disease susceptibility in Egyptian patients: a case–control observational study
  • 13 Apr 2026
  • Future Journal of Pharmaceutical Sciences
Enhanced antidiabetic efficacy and bioavailability of curcumin-loaded sporopollenin microcapsules in a type 2 diabetes rat model
  • 4 May 2026
  • Future Journal of Pharmaceutical Sciences
Antioxidant adjuvants as a strategy to combat multidrug-resistant gram-negative bacteria: mechanistic insights and translational perspectives
  • 16 Apr 2026
  • Future Journal of Pharmaceutical Sciences
Maintenance low-dose capecitabine versus observation in early-stage triple-negative breast cancer: a randomized controlled trial assessing safety with exploratory survival outcomes
  • 13 Apr 2026
  • Future Journal of Pharmaceutical Sciences
The double-edged sword of meat preservation: a review of nitrosamine genotoxicity, exposure in the egyptian market, and future alternatives
  • 13 Apr 2026
  • Future Journal of Pharmaceutical Sciences
Zinc and selenium in the management of subclinical hypothyroidism: mechanistic insights, clinical evidence, and translational perspectives
  • 13 Apr 2026
  • Future Journal of Pharmaceutical Sciences
Assessing the genetic contribution of certain GAS6/AXL variants to diabetic kidney disease susceptibility in Egyptian patients: a case–control observational study
  • 13 Apr 2026
  • Future Journal of Pharmaceutical Sciences

FAQs on FUTURE JOURNAL OF PHARMACEUTICAL SCIENCES